Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NO/redox disequilibrium in the failing heart and cardiovascular system
Joshua M. Hare, Jonathan S. Stamler
Joshua M. Hare, Jonathan S. Stamler
Published March 1, 2005
Citation Information: J Clin Invest. 2005;115(3):509-517. https://doi.org/10.1172/JCI24459.
View: Text | PDF
Review Series

NO/redox disequilibrium in the failing heart and cardiovascular system

  • Text
  • PDF
Abstract

There is growing evidence that the altered production and/or spatiotemporal distribution of reactive oxygen and nitrogen species creates oxidative and/or nitrosative stresses in the failing heart and vascular tree, which contribute to the abnormal cardiac and vascular phenotypes that characterize the failing cardiovascular system. These derangements at the integrated system level can be interpreted at the cellular and molecular levels in terms of adverse effects on signaling elements in the heart, vasculature, and blood that subserve cardiac and vascular homeostasis.

Authors

Joshua M. Hare, Jonathan S. Stamler

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
(A) Spatial localization of NOSs and oxidases in the cardiac myocyte. NO...
(A) Spatial localization of NOSs and oxidases in the cardiac myocyte. NOS3 localizes to the sarcolemmal caveolae (85, 97), where it participates in regulation of L-type Ca2+ channel (LTCC) currents, mediated either by cGMP formation (S64) or by S-nitrosylation of the LTCC (S13). NOS1 localizes to the SR (32), where it facilitates the SR Ca2+ cycle (97) by S-nitrosylation of the RyR and possibly the SR Ca2+ ATPase (SERCA2a) (17, 33). XOR also localizes to the SR in the cardiac myocyte; upregulation of protein or activity (caused by SR NOS1 deficiency) disrupts SNO regulation of the RyR (22). Other oxidases (e.g., NADPH oxidase) have been described in the cardiac myocyte (50), but precise signaling roles, identities, and/or subcellular localizations have not been elucidated. The mitochondria are an additional source of both O2– and NO, which may participate in control of mitochondrial respiration (S65–S67) and apoptosis (S41). Cyt, cytochrome; PLB, phospholamban. (B) Regulation of the RyR by S-nitrosylation. S-nitrosylation occurs at a single cysteine residue (1 of approximately 50 free thiols), which resides within a calmodulin-binding domain of the cardiac RyR (17). NO binding (shown for RyR1 of skeletal muscle) occurs in an oxygen-concentration–dependent manner and primes the channel for calmodulin regulation (18). Higher pO2 oxidizes a small set of RyR-associated thiols that regulate the channel’s responsiveness to NO. SH, reduced thiol; S-S, oxidized thiols; CAM, calmodulin; x refers to a small set between 1 and 3.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts